Desidustat in the Treatment of Anemia in CKD

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2019
This is a phase III, multicenter, multi‐country, open‐label, randomized, active‐controlled clinical trial to evaluate the efficacy and safety of Desidustat versus Darbepoetin for the treatment of anemia in patients with CKD who are not on dialysis. The study will be conducted over a period of up to 30 weeks.
Epistemonikos ID: 27bda760db824a56c560266a3c0abd740e9498f4
First added on: Dec 20, 2022